Hos disse patienter bør tolerancen over for kombinationsbehandlingen samt prognostiske faktorer såsom graden af fibrose tages med i overvejelserne, når der tages beslutning om behandlingsvarighed.
In these patients, tolerability to combination therapy and additional prognostic factors such as degree of fibrosis should be taken into account when deciding on treatment duration.